RCRI and MACE Risk: What It Predicts and What It Misses
The Revised Cardiac Risk Index estimates patient-level MACE risk from six factors. It is a reliable starting point — but it does not measure current stability, and it should never decide surgery or testing on its own.
Key points
- RCRI estimates patient-level statistical MACE risk from six equally weighted factors. It is a starting point, not a stop/go switch.
- The six factors: high-risk surgery, ischemic heart disease, heart failure, cerebrovascular disease, insulin-treated diabetes, and creatinine > 2.0 mg/dL.
- RCRI predicts statistical risk across a population. It does not measure current stability, functional capacity, or the severity of any single condition.
- A reassuring RCRI does not rule out an active cardiac condition, and a high RCRI is not by itself a reason to cancel surgery or order more tests.
- RCRI is one input in the Navigator — read it alongside surgical risk, functional capacity, and biomarkers.
When to use this page
When you have calculated an RCRI and need to know what it does and does not tell you. When an RCRI score is being used to justify cancelling surgery or ordering tests. When you want to understand how RCRI fits with functional capacity, BNP, and surgical risk.
RCRI estimates patient-level statistical risk, not current stability
Key point
The Revised Cardiac Risk Index estimates the statistical probability of a major adverse cardiac event from six patient and surgical factors. It describes risk across a population of similar patients — it does not measure whether this particular patient is stable today.
RCRI is one of the most widely used perioperative risk tools because it is simple, validated, and reproducible. Each of its six factors counts equally, and the total corresponds to a band of MACE risk. That simplicity is its strength — and the source of its limitations.
The six factors and what the score means
- High-risk surgery (intraperitoneal, intrathoracic, or suprainguinal vascular)
- History of ischemic heart disease
- History of congestive heart failure
- History of cerebrovascular disease (stroke or TIA)
- Insulin-treated diabetes mellitus
- Preoperative creatinine > 2.0 mg/dL (≈ 177 µmol/L)
The factors are summed, and the total maps to an estimated MACE risk: roughly 0.4% at 0 factors, 1% at 1 factor, 2–7% at 2 factors, and 10% or more at 3 or more. The risk rises with each factor — but every factor counts the same, regardless of how severe or how well controlled it is.
What RCRI predicts well
Key point
RCRI is a reliable, reproducible estimate of statistical risk across a population. For an individual patient, it provides a defensible baseline and a common language for discussing risk — which is exactly what it was designed to do.
Used as intended, RCRI answers one question: relative to other surgical patients, where does this patient's risk-factor burden place them? That is genuinely useful for framing a conversation, deciding when to look harder, and documenting risk.
What RCRI misses
Key point
RCRI does not measure current stability, functional capacity, the severity of any individual condition, or the presence of an active cardiac condition. A reassuring RCRI in an unstable patient is a false reassurance.
- Current stability — RCRI counts a history of heart failure or ischemic disease, but not whether it is decompensating today
- Severity and control — well-controlled and poorly controlled versions of the same condition score identically
- Functional capacity — RCRI does not capture exercise tolerance, which independently predicts outcome
- Active conditions — a patient with an active cardiac condition can still have a low RCRI
- Newer predictors — biomarkers such as BNP / NT-proBNP add predictive information beyond RCRI
Do not let RCRI alone decide surgery or testing
Key point
A high RCRI is not, by itself, a reason to cancel surgery or order more tests; a low RCRI is not, by itself, a guarantee of safety. RCRI sets the baseline — the decision comes from combining it with surgical risk, functional capacity, and biomarkers.
An elevated RCRI should prompt a more careful look — at functional capacity, at whether a biomarker would change the plan, at whether cardiology input would help — not an automatic cascade of tests. Equally, a low RCRI does not end the assessment if functional capacity is poor or an active condition is suspected. RCRI starts the reasoning; it does not finish it.
Where RCRI sits in the Cardiac Navigator
In the perioperative assessment, RCRI is the patient-side risk-burden input. It is read alongside surgical risk (the procedure axis), functional capacity (the reserve axis), and biomarkers (refinement when the picture is uncertain). The Navigator integrates these rather than letting any single one decide — which is the whole point of a structured assessment.
Common mistakes
- ✗ Treating RCRI as a stop/go switch for surgery
- ✗ Reading a low RCRI as proof the patient is stable today
- ✗ Ordering tests off a high RCRI without asking what decision the result would change
- ✗ Forgetting that high-risk surgery is itself one of the six factors — so the score already partly reflects the procedure
Basis for this approach
Lee et al., Derivation and Prospective Validation of a Simple Index for Prediction of Cardiac Risk of Major Noncardiac Surgery (Circulation 1999) / ACC/AHA 2014 Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery / ESC 2022 Guidelines on Cardiovascular Assessment and Management of Patients Undergoing Non-cardiac Surgery
Continue learning
Dyspnea on Stairs: Is Functional Capacity Really Adequate?
Patients often report that they are 'active' or 'walking regularly.' That does not mean they have adequate functional capacity. This case teaches how to move from symptom to functional limitation to perioperative decision.
Elevated BNP Before Surgery: A Signal, Not a Diagnosis
BNP 250 pg/mL. An elevated BNP does not diagnose heart failure. It signals that cardiac stress may be present. The key question is why it is elevated.
A Prior PCI Is Not the Whole Story: Assessing Coronary Disease Before Surgery
When a patient has a history of PCI, the first question is not about antiplatelet therapy. The first question is whether coronary artery disease remains stable today.
Apply this in practice
RCRI calculated → integrate it with FC and surgical risk in the Navigator
Verify this decision in the tool →